{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pulmonary-embolism/diagnosis/when-to-suspect/","result":{"pageContext":{"chapter":{"id":"1db70c8e-a80c-587a-8e5e-5adf28878587","slug":"when-to-suspect","fullItemName":"When to suspect","depth":2,"htmlHeader":"<!-- begin field 364991ed-fc63-4964-b4ab-d216f71f1ceb --><h2>When should I suspect pulmonary embolism?</h2><!-- end field 364991ed-fc63-4964-b4ab-d216f71f1ceb -->","summary":"","htmlStringContent":"<!-- begin item 82a3dbcb-4149-4c0f-a2c4-54a7641a5c54 --><!-- begin field d95b148f-3894-445a-b4fd-33c9c5692a00 --><ul><li><strong>Suspect pulmonary embolism (PE) in a person with dyspnoea, tachypnoea, pleuritic chest pain, and/or features of deep vein thrombosis </strong><strong>(DVT), </strong>including leg pain and swelling (usually unilateral), lower abdominal pain, redness, increased temperature, and venous distension<strong>.</strong><ul><li><strong>Other symptoms that may be present include:</strong><ul><li>Retrosternal chest pain (due to right ventricular ischaemia).</li><li>Cough and haemoptysis.</li><li>In severe cases, dizziness and/or syncope (due to right ventricular failure). </li></ul></li><li><strong>Other signs that may be present include:</strong><ul><li>Tachycardia (heart rate greater than 100 beats per minute).</li><li>Hypoxia.</li><li>Pyrexia.</li><li>Elevated jugular venous pressure.</li><li>Gallop rhythm, a widely split second heart sound, tricuspid regurgitant murmur.</li><li>Pleural rub.</li><li>Hypotension (systolic blood pressure less than 90 mmHg) and cardiogenic shock (rare signs indicating central PE and/or a severely reduced haemodynamic reserve).</li></ul></li><li><strong>The presence of <a class=\"topic-reference internal-reference\" href=\"/topics/pulmonary-embolism/background-information/risk-factors/\">risk factors</a>, </strong>such as pregnancy, previous DVT or PE, active cancer, or recent surgery, makes the diagnosis of PE more likely.</li><li><strong>Be aware that PE </strong>may be completely asymptomatic and be discovered incidentally when assessing for another condition. </li></ul></li><li><strong>If PE is suspected:</strong><ul><li><strong>Carry out an assessment of their general medical history, a physical examination, and, where necessary, investigations (such as a chest X-ray or electrocardiogram [ECG])<strong> </strong>to:</strong><ul><li>Exclude <a class=\"topic-reference internal-reference\" href=\"/topics/pulmonary-embolism/diagnosis/differential-diagnosis/\">other causes&nbsp;of symptoms</a>, including other respiratory conditions (such as pneumothorax and pneumonia) and cardiac causes (such as acute coronary syndrome and acute congestive heart failure).</li><li>Assess for <a class=\"topic-reference internal-reference\" href=\"/topics/pulmonary-embolism/background-information/risk-factors/\">risk factors</a> (such as pregnancy and immobilization).</li></ul></li><li><strong>Do not delay <a class=\"topic-reference internal-reference\" href=\"/topics/pulmonary-embolism/management/suspected-pulmonary-embolism/#primary-care-management\">management</a> for results of a chest X-ray or ECG.</strong><ul><li>Abnormalities on chest X-ray or ECG are not specific for PE, but might be useful in the differential diagnosis.<ul><li>Chest X-ray features that may be present include atelectasis, pleural effusion, or elevation of a hemidiaphragm.</li><li>ECG signs that may be present include sinus tachycardia, non-specific ST-segment and T-wave abnormalities, right axis deviation, incomplete or complete right bundle-branch block, and, less commonly, T-wave inversion in leads V1–V3, P pulmonale, or the classical S1, Q3, T3 (S wave in lead 1, Q wave in lead 3, and T-wave inversion in lead 3).</li></ul></li></ul></li></ul></li></ul><!-- end field d95b148f-3894-445a-b4fd-33c9c5692a00 --><!-- end item 82a3dbcb-4149-4c0f-a2c4-54a7641a5c54 -->","topic":{"id":"322088c5-226e-5f2b-9fd2-2e2c0678abc1","topicId":"6b233aab-5318-4abb-96fa-1877e917ef2c","topicName":"Pulmonary embolism","slug":"pulmonary-embolism","lastRevised":"Last revised in October 2020","chapters":[{"id":"7d60ce89-0a3c-5336-a5d4-755eb5bfb2cd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"99df9a07-7867-5283-b7c8-4589c8f6e029","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b4da2d8a-f835-512f-b218-660b7fc61806","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c60f44ed-a5f4-566e-8718-a289b4d4e969","slug":"changes","fullItemName":"Changes"},{"id":"42a750f4-f134-55a8-a654-9c23ac2a3bfd","slug":"update","fullItemName":"Update"}]},{"id":"b8001d19-4cf2-5db4-b8b5-f082fbff4fbd","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"52656989-9cf4-597c-8118-0fadcb887b21","slug":"goals","fullItemName":"Goals"},{"id":"cdd140ec-bd30-59e9-9777-c921159ea664","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c32413cc-9382-5aaa-b03b-95ed29a1b360","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c1a308a6-aa46-578f-98f1-ed7872474fb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1629cec2-329a-5273-a313-15a0783d5b22","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d4860e1f-9b8b-5f49-bdb5-fb068af327ab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9e6802a1-b9c3-5fa9-b632-ef9712c1724b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"588bb6e5-794e-52df-9953-d91254204285","slug":"definition","fullItemName":"Definition"},{"id":"e2fbb90b-8419-52d9-bfd2-a9eab621be3b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad38abd5-7668-59b3-828a-9edd427dbdd5","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"9b45f610-d957-50a3-9e85-019832acd145","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e279dc8-2394-5073-8866-952291c0eee6","slug":"complications","fullItemName":"Complications"},{"id":"8be5980d-145d-5d9c-b255-f057579ce868","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"c07c0850-0c27-58a8-96a8-96051968c076","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1db70c8e-a80c-587a-8e5e-5adf28878587","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"a71fc8ea-c1d7-5be5-a888-41b834fdca93","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f18a5246-939d-51ce-adb5-f6538871345a","fullItemName":"Management","slug":"management","subChapters":[{"id":"42f102a2-ceab-531f-880e-4075895d9c12","slug":"suspected-pulmonary-embolism","fullItemName":"Scenario: Suspected pulmonary embolism"},{"id":"cd66b55b-908e-56dc-811f-db55be20b710","slug":"confirmed-pulmonary-embolism","fullItemName":"Scenario: Confirmed pulmonary embolism"}]},{"id":"6ae8a494-48a2-5d60-b0f8-39dd5e02489b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8b812684-b06c-50e2-86d7-f012b792c674","slug":"parenteral-anticoagulants","fullItemName":"Parenteral anticoagulants"},{"id":"f367e7b5-6b1b-5f42-9d57-a8edab35855f","slug":"oral-anticoagulants","fullItemName":"Oral anticoagulants"}]},{"id":"c1bef62c-2c5a-5588-af53-1a0b4b26d3e3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3941fd8f-10fb-53d4-8dc1-3835ad3ca3e3","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"26fc4bf9-2995-5109-9f1e-3ba9ad3dd2dd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f1b2f1f8-81e2-5a3c-b454-2f63f66f6235","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"83fd7f66-6953-54a6-b55f-8d2858a82e97","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd9e363f-a674-594d-8bb9-8779d385e06a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"20c76427-9b00-5da0-bd68-6486385780f2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96a22dd0-587f-5051-8263-acea49ba216b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c07c0850-0c27-58a8-96a8-96051968c076","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"ef2ef732-c846-5de2-9813-82e30f6795bb","slug":"basis-for-recommendation-9ed","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 71bbbdc5-a1a1-414f-8b0b-fc0035203d90 --><h3>Basis for recommendation</h3><!-- end field 71bbbdc5-a1a1-414f-8b0b-fc0035203d90 -->","summary":null,"htmlStringContent":"<!-- begin item 9ed0934f-424f-4335-8054-97f2918decda --><!-- begin field ab746356-29fe-4e70-865d-a288c159479f --><h4>Clinical features and risk factors</h4><ul><li>These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guidelines <em>Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing</em> <em>(full NICE guideline) </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">National Clinical Guideline Centre, 2012</a>] and <em>Venous thromboembolic diseases: diagnosis, management and thrombophilia testing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">NICE, 2015a</a>], and the <em>2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>]. <ul><li>The symptoms and signs of pulmonary embolism (PE) are based on the NICE guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">National Clinical Guideline Centre, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">NICE, 2015a</a>].</li><li>In a study identified in the ESC guideline, the clinical characteristics of people with suspected (n = 528) and confirmed (n = 1880) PE in the emergency department were<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>]:<ul><li>Dyspnoea — 51% and 50%, respectively.</li><li>Pleuritic chest pain — 28% and 39%, respectively.</li><li>Cough — 23% and 23%, respectively.</li><li>Signs of deep vein thrombosis (DVT) — 18% and 24%, respectively.</li><li>Substernal chest pain — 17% and 15%, respectively.</li><li>Fever — 10% and 10%, respectively.</li><li>Haemoptysis — 4% and 8%, respectively.</li><li>Syncope — 6% and 6%, respectively.</li><li>Unilateral leg pain — 5% and 6%, respectively.</li></ul></li><li>Evidence from a prospective study on the accuracy of clinical features and risk factors for diagnosing PE found that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Stein et al, 2007</a>]:<ul><li>Most people (97%) with PE have either dyspnoea, tachypnoea, pleuritic chest pain, or clinical features of DVT.</li><li>The presence of either dyspnoea, tachypnoea, pleuritic chest pain, or symptoms or signs of DVT (in people with suspected PE) had a sensitivity for diagnosing PE of 97% and a negative predictive value of 77%, but a specificity of 13% and a positive predictive value of 23%</li></ul></li><li>A systematic review and meta-analysis of the value of individual clinical features in the diagnosis of PE found that individual clinical features only slightly raise or lower the probability of PE. However [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">West et al, 2007</a>]:<ul><li>The most useful features for ruling in<em> </em>PE (likelihood ratios significantly greater than 1) were syncope, shock, current DVT, leg swelling, sudden dyspnoea, active cancer, recent surgery, haemoptysis, leg pain, and possibly thrombophlebitis.</li><li>The most useful features for ruling out PE (likelihood ratios less than 1) were absence of sudden dyspnoea, absence of any dyspnoea, and absence of tachypnoea.</li></ul></li><li>The ESC highlights that PE may be completely asymptomatic and be discovered incidentally during diagnostic work up for another condition or at autopsy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>].</li></ul></li></ul><h4>History, examination, and investigations</h4><ul><li>NICE recommends that if a person presents with signs or symptoms of PE, an assessment of their general medical history, a physical examination, and a chest X-ray should be carried out to exclude other causes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">National Clinical Guideline Centre, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">NICE, 2015a</a>].</li></ul><h4>Electrocardiogram (ECG) and chest X-ray findings associated with PE</h4><ul><li>This information is based on expert opinion in the ESC guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>], a review article on DVT and PE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Di Nisio, 2016</a>],  and the Oxford textbook of medicine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Stein, 2010</a>].</li></ul><!-- end field ab746356-29fe-4e70-865d-a288c159479f --><!-- end item 9ed0934f-424f-4335-8054-97f2918decda -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}